CCNL2 and ventricular septal defect 1: Zhuo et.al have revealed that Cyclin L2 expression was upregulated in ventricular septum tissue of ventricular septal defect (VSD) patients, and demonstrated that Cyclin L2 can regulate growth, differentiation, and apoptosis of P19 cells via inhibiting the WNT pathway [34].